In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Astellas, Potenza ally in immuno-oncology therapies; Astellas later acquires company

Executive Summary

Astellas Pharma Inc. and Potenza Therapeutics Inc. teamed up to discover and develop cancer immunotherapies that target immune checkpoint pathways, co-stimulatory signals, and regulatory T cells.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Includes M&A Option
    • R&D and Marketing (Licensing)

Related Companies